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However, their tissue distibution differs (Hoey et al.,Harvard School of Public Health
1995; Northrop et al., 1994), as does their inducibilityDepartment of Medicine
after stimulation of T cells by T cell receptor (TCR) liga-Harvard Medical School
tion or phorbol esters plus calcium ionophore (NorthropBoston, Massachusetts 02115
et al., 1994). NF-ATp and NF-AT3 are expressed in virtu-²Tularik, Incorporated
ally all tissues, while NF-ATc and NF-AT4/x are preferen-270 East Grand Avenue
tially expressed in lymphoid organs and thymus withSouth San Francisco, California 94080
particularly high expression of NF-AT4/x in thymus (Ho
et al., 1995; Hoey et al., 1995; Masuda et al., 1995; Nor-
throp et al., 1994). Further, while transcripts encodingSummary
NF-ATc are markedly increased after T cell stimulation,
transcripts for NF-ATp are higher at baseline and do notNF-ATp is a member of a family of genes that encodes
change upon stimulation (Northrop et al., 1994). Thesethe cytoplasmic component of the nuclear factor of
observations raised the possibility that the functions ofactivated T cells (NF-AT). In this study, we show that
NF-AT family members may not be overlapping.mice with a null mutation in the NF-ATp gene have
NF-ATp was the first member of this family to besplenomegaly with hyperproliferation of both B and T
purified and cloned (McCaffrey et al., 1993). To addresscells. They also display early defects in the transcrip-
whether NF-ATp may have unique functions, we gener-tion of multiple genes encoding cytokines and cell
ated mice with a targeted mutation in the NF-ATp gene.surface receptors, including CD40L and FasL. A strik-
Mice that lack functional NF-ATp display hyperprolifera-ing defect in early IL-4 production was observed after
tion and dysregulation in the production of IL-4.ligation of the TCR complex by treatment with anti-
CD3 in vivo. The transcription of other cytokines in-
Resultscluding IL-13, GM±CSF, and TNFa was also affected,
though to a lesser degree. Interestingly, the cytokines
Generation of NF-ATp-Deficient MiceIL-2 and IFNg were minimally affected. Despite this
To generate mice deficient for NF-ATp, genomic DNAearly defect in IL-4 transcription, Th2 development
containing an exon encoding 47 aa of the highly con-was actually enhanced at later timepoints as evi-
served Rel homology domain was targeted for deletiondenced by increased IL-4 production and IgE levels in
and replaced by insertion of a neomycin resistance genesituations that favor the formation of Th2 cells both in
(neo1) (Figure 1A). Germline chimeras generated fromvitro and in vivo. These data suggest that NF-ATp may
one gene-targeted embryonic stem (ES) cell clone (Fig-
be involved in cell growth, and that it is important for
ure 1B) produced heterozygous mice that were then
the balanced transcription of the IL-4 gene during the
bred to produce mice homozygous for the disrupted
course of an immune response. allele, hereafter referred to as (2/2) mice (Figure 1C).
Western blot analysis of (2/2) extracts using a mono-
Introduction clonal antibody (MAb) specific for a region animo termi-
nal to the NF-ATp Rel homology domain revealed an
Ligation of the T lymphocyte antigen receptor triggers absence of full-length NF-ATp proteins (Figure 1D).
the expression of multiple early activation genes encod- Western blot analysis using an NF-ATc-specific MAb
ing cytokines and surface receptor molecules. Nuclear demonstrated that NF-ATc is expressed normally in NF-
factor of activated T cells (NF-AT) was first described ATp (2/2) mice and that the extracts used to assess
as a transcriptional regulatory complex critical for the the status of NF-ATp were not degraded (Figure 1D).
expression of the T cell cytokine, interleukin-2 (IL-2) Two smaller polypeptides reactive with the NF-ATp anti-
(Shaw et al., 1988). Subsequently, the IL-4, granulocyte± body were observed in (2/2) cytoplasmic extracts, but
macrophage colony-stimulating factor (GM±CSF), and a nearly undetectable amount of either form is found
tumor necrosis factor-a (TNFa) cytokine genes were in the nucleus (Figure 1D). Extracts from heterozygous
shown to be regulated by NF-AT (Cockerill et al., 1995; (1/2) cells contained polypeptides present in both the
Goldfeld et al., 1993; Rooney et al., 1994). NF-AT is (1/1) and the (2/2) cell extracts (Figure 1D). Sequence
composed of a cytoplasmic subunit, whose transloca- analysis of RT±PCR products from (2/2) RNA revealed
tion to the nucleus is cyclosporin sensitive, and an in- the presence of spliced in-frame transcripts, which pre-
ducible nuclear component composed of AP-1 family cisely remove the targeted exon (amino acids 398±444;
member proteins (Flanagan et al., 1991; Jain et al., 1992). data not shown). Electrophoretic mobility shift assay
The cytoplasmic subunit of NF-AT isencoded by a family (EMSA) of polypeptides corresponding to the mutant
of genes including NF-ATp, NF-ATc, NF-AT3, and NF- allele, generated from NF-ATp cDNA from (2/2) spleno-
cytes (Figure1E), indicated that this mutation leads to anAT4/x, all of which can bind to and transactivate NF-AT
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Figure 1. Disruption of the Murine NF-ATp Gene
(A) The structure of the genomic DNA encoding a portion of the NF-ATp Rel similarity domain isolated from a 129/sv genomic library (top).
Replacement construct containing the neo cassette indicating the replacement of the segment containing the Rel homology domain exon
with the neo cassette (middle). Gene structure of a portion of the locus bearing a deletion in the NF-ATp gene (bottom). R, B, E, H, and X
indicate recognition sites for the restriction enzymes EcoRI, BamHI, Eco47III, HindIII, and XbaI, respectively.
(B) Southern blot analysis of EcoRI-digested genomic DNA from representative ES clones bearing disrupted (1/2) or intact (1/1) NF-ATp
alleles.
(C) Genotype analysis of mice bearing mutant NF-ATp alleles.
(D) Western blot analysis of NF-AT polypeptides in extracts of NF-ATp mutant mice. Cytoplasmic or nuclear extracts from wild-type (1/1),
heterozygous (1/2), or homozygous NF-ATp mutant (2/2) mice separated by SDS±PAGE were blotted and probed with anti-NF-ATp or NF-
ATc antibodies. The positions of molecular mass markers (in kDa) are indicated to the right.
(E) Rel domain polypeptides from wild-type or mutant NF-ATp genes. Autoradiogram showing protein expression of the control (lane 1) or
the wild-type (lane 2) and mutant (lane 3) forms of NF-ATp Rel domains. The proteins were expressed in an in vitro transcription/translation
extract and labeled with 35S. The positions of molecular mass size markers (in kDa) are indicated to the left of the gel.
(F) EMSA comparing the DNA binding activities of the wild-type and mutant NF-ATp proteins. Reactions in lanes 1±4 were carried out with
0.1, 0.3, 1, and 3 ml of the control extract; lanes 5±8 and lanes 9±12 contained the same amounts of extract containing wild-type or mutant
NF-ATp Rel domain, respectively.
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the NF-ATp (2/2) mice were bred onto the DO11.10Table 1. Cell Recoveries from NF-ATp (2/2) Spleens
ovalbumin TCR transgenic line, there was a 1.7-fold in-
Splenocytes (3 106 cells)
crease in numbers of lymphocytes recovered after aAge (1/2) (2/2) Ratio
primary in vitro stimulation of transgenic spleen cells
12 weeks 59 47 0.79 with ovalbumin (data not shown). We conclude that NF-
14 weeks 84 96 1.17
ATp is important in regulating the proliferation of CD4116 weeks 116 142 1.22
T cells in response to signals delivered through the TCR.18 weeks 76 156 2.07
Since cytokine expression has been proposed to play
Average 1.31
a role in thymocyte development (Carding et al., 1991),
Splenic cell suspensions from control (1/2) or NF-ATp (2/2) mice and NF-AT activity can be detected in thymocytes (Sen
were depleted of erythrocytes and the cell number was determined. et al., 1994), we examined the surface phenotype of
The number of NF-ATp (2/2) cells divided by the number of control
thymocytes by flow cytometry (Figure 2D). Thymocytescells for each timepoint or the average for all timepoints is expressed
from NF-ATp (2/2) mice resembled (1/2) or (1/1) con-as Ratio.
trol littermates with respect to CD4 and CD8 levels and
distribution of subsets (Figure 2D). Examination of other
markers of T cell development including CD44, CD69,
abrogation of DNA binding activity (Figure 1F). Indeed, HSA, IL-2Ra, and TCRa/b also didnot reveal any defects
previous analyses of NF-ATp truncation mutants indi- in the maturation of NF-ATp (2/2) thymocytes (data not
cate that residues in the region from 375±410 are critical shown). Thymic development thus proceeds normally
for high affinity DNA binding (Jain et al., 1995). Although in the absence of wild-type NF-ATp.
the truncated protein cannot bind DNA, it could poten-
tially interfere with accessory proteins that interact with
other NF-AT family members. However, the analyses Defective Induction of CD40 Ligand and Fas
described below did not reveal a similar phenotype in Ligand in NF-ATp (2/2) Mice
the heterozygous and the deficient mouse, indicating The T cell hyperproliferation observed above prompted
that a dominant negative effect did not arise from this us to examine the induction of several early activation
mutation. Taken together, these data indicate that this genes in NF-ATp (2/2) mice. T cells were stimulated in
alteration of the NF-ATp gene is a loss of function mu- vivo by ligation of the TCR by injection of antibodies to
tation. CD3, and early gene activation assessed by Northern
blot analysis of spleen RNA harvested 1 hr postinjection.
Splenomegaly and Hyperproliferation The mRNAs encoding CD40 ligand (CD40L) and Fas
in NF-ATp (2/2) Mice ligand (FasL) were substantially reduced following in
Homozygous mutant mice were born at the expected vivo stimulation with anti-CD3 antibodies, while the ex-
Mendelian ratio, were fertile, and appeared healthy until pression of CD69 mRNA was only moderately affected
at least 6 months of age. Although NF-ATp is expressed (Figure 3A). These data are consistent with the presence
in multiple organs, including the central nervous system of NF-AT target sites in the CD40L promoter (Tsitsikov
(Ho et al., 1994), the only gross pathologic or histologic et al., 1994).
abnormality noted was moderate splenomegaly due to
an increased number of both lymphoid and erythroid
cells. The relative number of mononuclear cells in Early Impairment of IL-4 Expression
in NF-ATp (2/2) Micespleens of NF-ATp (2/2) mice compared with control
mice increases with age with an approximately 2-fold NF-ATp was initially described as a transcription factor
important in the regulation of multiple cytokine genes.increase by 18 weeks (Table 1). Although there were
increased numbers of cells in spleens from (2/2) com- To test whether NF-ATp is indeed important in cytokine
gene regulation upon signaling through the TCR, wepared with (1/2) mice, the percentage of B cells, and
CD41 and CD81 T cells, was not substantially different chose the following system. In vivo ligation of the TCR
complex by treatment with anti-CD3 antibodies resultsfrom control littermates (Figure 2A). Proliferative re-
sponses of B lymphocytes from NF-ATp (2/2) mice to in a rapid (60±90 min) and transient increase in the levels
of multiple cytokine transcripts, including IL-2, IL-4, andsaturating doses of anti-CD40 and anti-immunoglobulin
M (IgM) were slightly elevated compared with those from interferon-g (IFNg) (Scott et al., 1990; Yoshimoto and
Paul, 1994). This system allowed us to test whethercontrol littermates (Figure 2B). In addition, the prolifera-
tion of B lymphocytes from (2/2) mice stimulated with NF-ATp is indeed important in the initial regulation of
multiple cytokine genes. Control and NF-ATp (2/2) miceanti-IgM appeared slightly less sensitive to cyclosporin
A than those from (1/2) mice. These results suggest that were injected with antibodies to CD3. Anti-CD3-injected
(2/2) mice exhibited a striking defect in the inductionother NF-AT family members can largely compensate for
the lack of NF-ATp in mediating calcineurin-dependent of IL-4, with little or no mRNA detectable 1 hr after
treatment (Figure 3B). The transcription of the IL-13,events; alternatively, signaling pathways not involving
NF-AT proteins may be involved. GM-CSF, and TNFa genes was also reduced, although
to a somewhat lesser degree. The defect in the inductionTreatment of CD41T cells with anti-CD3 antibody in
vitro also revealed an increased proliferative capacity of these cytokines was observed in at least five separate
experiments. Surprisingly, IL-2, the cytokine whose reg-of NF-ATp (2/2) T cells as detected by incorporation
of [3H]thymidine (Figure 2C) and by cell recoveries at 48 ulation by NF-AT has been most extensively studied, did
not appear to be affected significantly by the absencehr following stimulation (data not shown). Further, when
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Figure 2. Flow Cytometric Analysis of Lymphocytes from NF-ATp (2/2) Mice
Splenocytes (A) or thymocytes (D) from 5-week-old control (1/2) or NF-ATp-deficient (2/2) mice were stained with fluorescein- (ordinate) or
phycoerythrin- (abscissa) conjugated antibodies to murine surface markers as indicated. (B) Proliferation of splenocytes from NF-ATp-deficient
mice. [3H]thymidine incorporation (cpm) by control (1/2) (open bars) or (2/2) (closed bars) splenocytes in response to plate-bound anti-IgM
(a-IgM), anti-CD40 (a-CD40) antibodies, or lipopolysaccharide (LPS). Anti-IgM treatment was also performed in the presence of 1 mg/ml
cyclosporin A (CsA). (C) [3H]thymidine incorporation (cpm) by control (1/2) (open bars) or (2/2) (closed bars) CD41 T cells in response to
plate-bound anti-CD3 or control hamster immunoglobulin.
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Figure 3. Northern Blot Analysis of Splenic RNA from Anti-CD3e-Treated Mice
RNA prepared from spleens of control mice (1/1 and 1/2) or NF-ATp mutant (2/2) mice injected with PBS (minus) or anti-CD3e antibody
(plus) was analyzed by Northern blot hybridization with probes specific for cytokine (A) or cell surface activation (B) genes as indicated.
Hybridization with a TCRa probe was used to control for relative quantity of RNA in each sample. (C) ELISA of cytokine expression by NF-
AT (2/2) lymphocytes. We incubated 5 3 105 splenocytes from control (1/2) or NF-AT mutant (2/2) mice for 48 hr in wells coated with 10
mg/ml of anti-CD3 antibody and supernatants assayed for levels of cytokines by ELISA (Pharmingen). Erythrocytes were removed as described
in Figure 2.
of NF-ATp. Furthermore, transcripts for IFNg were only later timepoints was impaired in NF-ATp (2/2) mice,
modestly affected by the disruption of the NF-ATp gene. the response of NF-ATp (2/2) or control littermates to
Consistent with the in vivo data, a striking decrease two different stimuli that evoke the production of IL-4
in induction of IL-4 mRNA was also observed upon and result in Th2-type responses in vitro and in vivo
Northern blot analysis of RNA from spleen cells stimu- was examined. To dissociate the early defect in IL-4
lated for 1 hr with anti-CD3 in vitro (data not shown). production from an effect of NF-ATp in driving IL-4 pro-
Consistent with the normal induction of IL-2 and IFNg duction at later time periods, we utilizedan invitro model
in vivo, primary in vitro stimulation of splenocytes from of T helper (Th) cell differentiation. Spleen cells from
(2/2) mice with immobilized anti-CD3 antibody for 48 four NF-ATp (2/2) or four control mice were stimulated
hr resulted in the secretion of normal levels of IL-2 and
in vitro with anti-CD3 in the presence of recombinant
IFNg both in the presence and absence of cyclosporin
IL-4, shown to be critical in priming for later IL-4 produc-A (Figure 3C). We conclude that NF-ATp is particularly
tion, so that Th2 development was not dependent onimportant in the early transcription of certain cytokine
endogeneous production. Cells were then restimulatedgenes, most notably, IL-4.
with anti-CD3 and supernatants harvested after 48 hr.
An increased level of IL-4 was clearlypresent in superna-Production of IL-4 at Later Timepoints
tants from NF-ATp (2/-) splenocytes as compared withas well as Th2 Development Is Increased
control cells (Figure 4). An increase in IL-4 was alsoin NF-ATp (2/2) Mice
observed even in the absence of exogeneous IL-4 (dataThe above experiments demonstrated a marked defect
not shown). We also looked at an in vivo immunein early IL-4 production following administration of anti-
CD3 in vivo. To test whether the production of IL-4 at response. Immunization with trinitrophenol (TNP)±
Immunity
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Figure 4. Cytokine Analysis of In Vitro-Differentiated T Lympho-
cytes from Control and NF-ATp (2/2) Mice
Spleen cells from four control and four NF-ATp (2/2) mice were
activated with anti-CD3 and cultured in the presence of recombinant
IL-4 as described in Experimental Procedures. After 7 days in cul-
ture, cells were restimulated and supernatants harvested 24 hr later
and analyzed for the presence of cytokines by ELISA using specific
antibodies according to the instructions of the manufacturer(Phar-
mingen). Horizontal bars represent the average cytokine expression
for each group of mice. Figure 5. Western Blot Analysis of NF-AT Proteins in NK1.11 Cells
Extracts from purified NK1.11 cells and control lymph node cells
ovalbumin resulted in increased levels of TNP-specific were probed with NF-AT-specific antibodies as described in Fig-
ure 1D.serum IgE antibodies in three NF-ATp (2/2) mice as
compared with three control mice (average 55.6 ng/ml
versus 14.6 ng/ml). Taken together, these data demon- lymphocytes in NF-ATp-deficient mice both at baseline
strate that, despite an initial defect in IL-4 production, and upon TCR ligation suggests a previously unknown
the absence of NF-ATp during an ongoing immune re-
role for this transcription factor in regulating cell growth.
sponse actually favors the formation of Th2 cells as
The increased proliferation of lymphocytes in NF-ATp-
evidenced both by increased IL-4 and IgE production.
deficient mice upon TCR ligation suggests a role for this
transcription factor in regulating cell growth, potentially
NK1.1 Cells Preferentially Express NF-ATp through the regulation of molecules such as CD40L and
IL-4 is produced by multiple cell types including Th2
FasL. There are known NF-AT binding sites in the CD40L
cells, mast cells, basophils, and a recently defined popu-
promoter, and our data raise the possibility that other
lation of CD41 T cells that bear the NK1.1 surface marker
genes involved in early T cell activation (such as FasL)
(Aramburu et al., 1995; Yoshimoto and Paul, 1994). This
will be found to contain NF-AT target sites. If so, then
small CD41, NK1.11 population of T cells has been
NF-ATp may play a global role in early T cell signaling.
shown to account for virtually all of the IL-4 produced
The increased lymphocyte numbers in these animalsin response to in vivo challenge with anti-CD3 (Carding
raise the possibility of a basal defect in apoptosis, dys-et al., 1991; Sen et al., 1994). A possible explanation for
regulation (or both) of the cell cycle, possibilities thatthe early in vivo defect in IL-4 transcription is that NF-
we are currently exploring. The hyperproliferation ob-ATp is critical in initiating IL-4 gene transcription in these
served in NF-ATp (2/2) lymphocytes after stimulationcells, but not in Th2 cells where other NF-AT family
through the TCR may be related to the defective induc-members can substitute, thus providing for a Th2 re-
tion of the FasL receptor. Indeed, the genetic defectsponse. To examine this issue, we therefore purified
that accounts for the striking lymphoproliferation ob-NK1.11 cells from splenocytes and performed Western
served in the gld mouse strain is a mutation in the FasLblot analysis on lysates using anti±NF-AT-specific anti-
gene resulting in a nonfunctional protein (Takahashi etbodies. While both NF-ATp and NF-ATc polypeptides
al., 1994).were present, NF-ATp was enriched relative to NF-ATc
The cytokine phenotype of the NF-ATp-deficient micein NK1.11 splenocytes compared with control unsepa-
revealed an important role for this factor in the regulationrated spleen cells (Figure 5, lanes 1 and 2). Unfortu-
of the IL-4 gene over time. Interestingly, a similar defectnately, the prohibitively small number of these cells that
in the early transcription of the IL-2 gene in vivo wascan be obtained did not allow us to compare directly
not observed, suggesting a more prominent role forthe binding activity of NF-ATp versus NF-ATc in nuclear
other NF-AT family members in the regulation of thisextracts.
cytokine. At early timepoints, NF-ATp is critical for ini-
tiating IL-4 gene transcription and other NF-AT familyDiscussion
members cannot substitute for NF-ATp. However, as
the immune response progresses, the absence of NF-Taken together, our analysis of NF-ATp (2/2) mice indi-
ATp actually results in an increased generation of IL-4.cates a predominant and essential role for NF-ATp in
We conclude that NF-ATp is critical for the balancedbalancing the transcription of the IL-4 gene during the
transcription of the IL-4 gene over time.course of an immune response, a function that cannot
The mechanisms involved in the differential effects ofbe compensated for by other NF-AT family members.
Further, the splenomegaly and increased proliferation of NF-ATp on early cytokine transcription are not clear but
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poly(A) cassette from pMC1neopoly(A) (Stratagene). The replace-may be related to the types of lymphocytes that produce
ment construct was prepared by transferring a BamHI to XhoI frag-particular cytokines. There are two possible, and not
ment containing 6 Kb of 59 NF-ATp sequence, the neo cassette, andmutually exclusive, explanations for these seemingly
3.5 kb of 39 NF-ATp sequence, to a plasmid encoding the thymidine
paradoxical effects of NF-ATp on IL-4 production. The kinase drug resistance gene. ES cell clones transfected with the
first explanation relies on differences in the kinetics of targeting construct were selected for drug-resistance in 180 mg/ml
G418 and 2 mM gancyclovir. To screen for homologous recombina-binding of the different NF-AT family members to the
tion, genomic DNA from drug-resistant clones was digested withIL-4 promoter. It is reasonable to hypothesize that NF-
EcoRI and analyzed by Southern blot hybridization to a 0.9 KbATp, which is present in unstimulated T cells, might be
BamHI±EcoRI probe (Figure 1, probe A). This probe detects an 11the first NF-AT protein to translocate to the nucleus and
kb EcoRI fragment in the wild-type allele and a 7 kb fragment in the
bind DNA after T cell stimulation, while NF-ATc, which neo disrupted allele. NF-ATp disruption in selected clones was also
is induced after stimulation, could replace it at later confirmed by analysis with a probe specific for the 39 end of the
deletion (Figure 1, probe B) (data not shown). Three different primerstimepoints. A deficiency in NF-ATp would then result in
indicated in Figure 1 were used to amplify a 500 bp fragment froman early and transient defect in IL-4 as observed here.
the wild-type allele or a 390 bp band from the disrupted NF-ATpIndeed, in preliminary studies, levels of transcripts for
allele using genomic DNA from individual mice. The common prim-IL-4 in CD4 T cells stimulated with anti-CD3 for varying
er NpIn1 (59-GCAAGCCTCAGTGACAAAGTATCCACTTCA-39) was
lengths of time reveals an early defect followed by an used at 1 mM and the two allele-specific primers NpEx1 (59-CCACGA
increase at later timepoints (A. M. R., unpublished obser- GCTGCCCATGGTGGAGAGACAAGA-39) and neoPCR (59-AGCGTT
GGCTACCCGTGATATTGCTGAAGA-39) were used at a concentra-vations). The second explanation involves the preferen-
tion of 0.5 mM.tial expression of NF-ATp in certain cell types respon-
sible for the early, but not late, release of IL-4 and is
Western Blot Analysis of NF-AT Polypeptidessupported by the experiments described above (Figure
Splenic extracts were prepared by treating 1 3 106 splenocytes
5). Interestingly, it has recently been shown that human with lysis buffer containing 1% NP-40 and separating nuclei by
natural killer (NK) cells, upon ligation of the CD16 recep- centrifugation at 500 3 g. NK1.11 cells were prepared from six MHC
tor, contain only NF-ATp and not NF-ATc binding activity class II±deficient C57BL/6 mice by depletion of CD81 and HSA1
cells by antibody-dependent complement lysis and adsorption to(Aramburu et al., 1995). The presence of enhanced Th2
anti-murine IgG-coated plates. Remaining live cells were staineddevelopment in NF-ATp-deficient mice despite the im-
with biotinylated anti-NK1.1 plus streptavidin±phycoerythrin andpairment in the early release of IL-4 differs from the
anti-CD4±flourescein isothiocyanate (Pharmingen), sorted into
recently reported defect in Th2 development in SJL mice NK1.11 and NK1.12 populations, and used to prepare whole cell
that have greatly diminished numbers of NK1.1 cells extracts. Extracted proteins were separated by 6% PAGE followed
(Yoshimoto et al., 1995). Strain background or the com- by electrotransfer to nitrocellulose membranes. Proteins were de-
tected by probing with MAbs specific for NF-ATp (4G6-G5 specificpensatory increase in IL-4 production that occurs at
for amino acids 145±189 of NF-ATp, gift of L. Timmerman) or NF-later time periods in NF-ATp-deficient mice mayaccount
ATc (7A6) (Ho et al., 1995) plus horseradish peroxidase±conjugatedfor these differences. Appropriate backcrossing of NF-
sheep F(ab9)2 anti-mouse immunoglobulin and enhanced chemilumi-ATp (2/2) mice to strains (e.g., C57BL/6) that express nescence according to the instructions of the manufacturer (Am-
the NK1.1 marker should allow us to establish defini- ersham).
tively the role of NF-ATp in cytokine gene transcription
DNA Binding Assay of Mutant NF-AT Polypeptidesin this interesting subpopulation of T cells.
The mutant form of NF-ATp cDNA was isolated by RT±PCR fromThe molecular basis for the effect of NF-ATp in con-
mRNA obtained from spleens of (2/2) mice. DNA sequence analysistrolling IL-4 production at later timepoints is unknown
indicated that in the mutant form of NF-ATp, the residues 398±444at present. The increase in IL-4 and IgE levels observed
in the C-terminal half of the Rel domain were deleted. A portion of
in in vitro-differentiated T cells and in the response to the wild-type murine NF-ATp cDNA (McCaffrey et al., 1993) encoding
TNP-ovalbumin demonstrated a clear preference for the amino acids 187±519, which spans the Rel homology domain, and
the equivalent region from the mutant NF-ATp cDNA, were sub-expansion of Th2 cells. Indeed, we have also found
cloned into the T7 expression vector TP7 (Hoey et al., 1995). Proteinsincreased amounts of IL-4 in spleencells harvested from
were expressed in an in vitro transcription/translation reticulocyteNF-ATp (2/2) mice 5 days after in vivo challenge with
extract (TnT, Stratagene) and labeled with [35S]methionine. DNAanti-IgD antibodies when compared with control ani-
binding activity was tested by gel mobility shift assay as previously
mals (M. R. H. and A. M. R., unpublished data). described (Hoey et al., 1995), using a labeled sequence correspond-
Taken together, our analysis of NF-ATp (2/2) mice ing to the distal NF-AT site from the murine IL-2 promoter (59-CAAAG
AGGAAAATTTGTTTCATA-39).indicates a critical role for NF-ATp in the regulation of
IL-4 expression and in Th2 development. The extent of
Flow Cytometric Analysisoverlap in the function of the other NF-AT family mem-
Single cell suspensions of 1 3 106 cells were incubated at 48C withbers in regulating cell proliferation and transcription of
fluorescein- or phycoerythrin-conjugated antibodies (Pharmingen)
cytokine and surface receptor genes will be best as- and analyzed using a FACScan (Becton Dickenson) flow cytometer
sessed by the generation of mice deficient for these using Lysis software. Dead cells were gated out by propidium iodide
proteins. (0.5 mg/ml) exclusion. Erythrocytes were depleted from splenic cell
suspensions by treatment with 8.3 g/ml NH4Cl in 10 mM Tris±HCl
(pH 7.5). Staining and analysis was performed onat least five animals
of each genotype with similar results.Experimental Procedures
Disruption of the NF-ATp Gene Analysis of Cell Proliferation
Splenocytes (5 3 105) from control (1/2) or NF-ATp (2/2) miceA cDNA fragment corresponding to the Rel homology domain of
the NF-ATp gene was used as a probe to isolate clones from a 129/ were incubated per well of a 96-well plate previously coated with
antibody. Cultures were pulsed at 48 hr with 1 mCi of [3H]thymidinesv genomic library. An Eco47III±HindIII fragment from the NF-ATp
genomic clone was replaced with a thymidine kinase promoter±neo± (New England Nuclear) and harvested 14 hr later. For analysis of B
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cell proliferation, plates were coated with 10 mg/ml anti-IgM, or 20 D., and Spriggs, M.K. (1992). Molecular and biological characteriza-
tion of a murine ligand for CD40. Nature 357, 80±82.mg/ml anti-CD40. IL-4 was added to a concentration of 100 U/ml in
samples treated with fixed anti-IgM antibodies. Lipopolysaccharide Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown, S.S., and Cer-
and cyclosporin A were added at a concentration of 20 mg/ml and ami,A. (1986). Identification of a common nucleotidesequence inthe
1 mg/ml, respectively. CD41 T cells were purified from splenocytes 39-untranslated region of mRNA molecules specifying inflammatory
and lymph node cells by depletion of MHC class II1, CD81, and mediators. Proc. Natl. Acad. Sci. USA 83, 1670±1674.
HSA1 cells using antibody-dependent complement lysis and ad-
Carding, S.R., Hayday, A.C., and Bottomly, K. (1991). Cytokines in
sorption to anti-IgG-coated plates. We incubated 1 3 105 purified
T-cell development. Immunol. Today 12, 239±245.
CD41 cells per well previously coated with anti-CD3e (1 mg/ml) anti-
Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., and Rutter, W.J.body and assayed for proliferation as described above.
(1979). Isolation of biologically active ribonucleic acid from sources
enriched in ribonuclease. Biochemistry 18, 5294±5299.
In Vivo Anti-CD3 Analysis
Cockerill, P.N., Bert, A.G., Jenkins, F., Ryan, G.R., Shannon, M.F.,Mice (5 weeks old) were injected with 100 ml PBS or PBS containing
and Vadas, M.A. (1995). Human granulocyte±macrophage colony-4 mg of purified anti-CD3e (145±2C11) antibody into the orbital sinus.
stimulating factor enhancer function is associated with cooperativeAt 1 hr postinjection, mice were sacrificed and spleens snap frozen
interactions between AP-1 and NF-ATp/c. Mol. Cell. Biol. 15, 2071±in liquid N2. Splenic RNA was prepared by the guanidinium/CsCl
2079.method (Chirgwin et al., 1979) and 10 mg fractionated by electropho-
Flanagan, W.M., Corthesy, B., Bram, R.J., and Crabtree, G.R. (1991).resis on 1.2% agarose, 6% formaldehyde gels. Identical gels were
Nuclear association of a T-cell transcription factor blocked by FK-blotted to Hybond N (Amersham) and hybridized with at least 1 3
506 and cyclosporin A. Nature 352, 803±807.106 cpm of random primer-labeled cDNA fragments per milliliter of
QuickHyb solution according to the instructions of the manufacturer Goldfeld, A.E., McCaffrey, P.G., Strominger, J.L., and Rao, A. (1993).
(Stratagene). cDNA fragments were purified from plasmids: IL-2, Identification of a novel cyclosporin-sensitive element in the human
IL-4, and IFNg (Yoshimoto and Paul, 1994), GM±CSF (Miyatake et tumor necrosis factor alpha gene promoter. J. Exp. Med. 178, 1365±
al., 1985), IL-10 (Hsu et al., 1990), TNFa (Caput et al., 1986), TCRa 1379.
(Saito et al., 1984), CD40L (Armitage et al., 1992), Fas-L (Takahashi Ho, A.M., Jain, J., Rao, A., and Hogan, P.G. (1994). Expression of
et al., 1994), CD69 (Ziegler et al., 1994), Fas (Rouvier et al., 1993), the transcription factor NF-ATp in a neuronal cell line and in the
or amplified using PCR with specific primers for IL-13 (McKenzie et murine nervous system. J. Biol. Chem. 269, 28181±28186.
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Ho, S.N., Thomas, D.J., Timmerman, L.A., Li, X., Francke, U., and13.3, 59-GCAGTTTTGTTATAAAGTGGGCT-39) and cDNA prepared
Crabtree, G.R. (1995). NF-ATc3, a lymphoid-specific NF-ATc familyfrom anti-CD3-stimulated D10.G4 T cell RNA (Kaye et al., 1983).
member that is calcium-regulated and exhibits distinct DNA binding
specificity. J. Biol. Chem. 270, 19898±19907.
Measurement of Cytokine and Antibody Levels by ELISA
Hoey, T., Sun, Y.L., Williamson, K., and Xu, X. (1995). Isolation ofWe incubated 5 3 105 splenocytes from control or NF-AT-deficient
two new members of the NF-AT gene family and functional charac-mice for 48 hr in wells coated with 10 mg/ml of anti-CD3e antibody
terization of the NF-AT proteins. Immunity 2, 461±472.and supernatants assayed for levels of IL-2 or IFNg by ELISA (Phar-
Hsu, D.H., de Waal Malefyt, R., Fiorentino, D.F., Dang, M.N., Vieira,mingen). Erythrocytes were depleted from splenic cell suspensions
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